| A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy T Rajakumar, R Horos, J Jehn, J Schenz, T Muley, O Pelea, S Hofmann, ... NPJ Precision Oncology 6 (1), 19, 2022 | 31 | 2022 |
| RNA-responsive gRNAs for controlling CRISPR activity: current advances, future directions, and potential applications O Pelea, TA Fulga, T Sauka-Spengler The CRISPR Journal 5 (5), 642-659, 2022 | 10 | 2022 |
| Past, present, and future of CRISPR genome editing technologies M Pacesa, O Pelea, M Jinek Cell 187 (5), 1076-1100, 2024 | 6 | 2024 |
| Specific Modulation of CRISPR Transcriptional Activators through RNA-Sensing Guide RNAs in Mammalian Cells and Zebrafish Embryos O Pelea, S Mayes, QRV Ferry, TA Fulga, T Sauka-Spengler bioRxiv, 2023.05. 08.539738, 2023 | 2 | 2023 |
| Engineering molecular RNA sensors for controlling CRISPR activity in vivo O Pelea University of Oxford, 2022 | | 2022 |
